Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes.
Ueda Y, Usuki K, Fujita J, Matsumura I, Aotsuka N, Sekiguchi N, Nakazato T, Iwasaki H, Takahara-Matsubara M, Sugimoto S, Goto M, Naoe T, Kizaki M, Miyazaki Y, Aakashi K.
Ueda Y, et al. Among authors: goto m.
Cancer Sci. 2022 Apr;113(4):1377-1392. doi: 10.1111/cas.15245. Epub 2022 Mar 9.
Cancer Sci. 2022.
PMID: 34932235
Free PMC article.
Clinical Trial.